Additionally, the correct spatial distribution among TAMs and tumor cells within the cancer matrix confirmed p65/p52 gene activation in BC, revealing an exacerbated overexpression specifically in TNBC subtype, in accordance with what observed in vivo, thus confirming its involvement in tECM remodeling. The gene discussed is NFKB2; the disease is cancer.